Amgen

Amgen is a pioneering biotechnology company focused on biologics, biosimilars, and innovative human therapeutics, with a pipeline spanning oncology, cardiovascular disease, and inflammation, and a long-standing commitment to applying computational methods in drug development. The company's engineering challenges include developing AI-driven platforms for protein engineering and molecular design, building data pipelines that connect high-throughput screening data with predictive models, and maintaining the manufacturing and supply chain systems required for large-molecule production. Their technology organization supports computational chemistry workflows, clinical data management, commercial analytics, and the regulated infrastructure that governs pharmaceutical operations. Amgen's hiring patterns reflect the biotech industry's shift toward AI-augmented drug discovery, with growing demand for ML engineers, bioinformatics specialists, and software engineers who can build production systems at the intersection of biology and computation.